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Abstract 
Colorectal  cancer  is  a  common  malignant
neoplasm in adults, with a peak incidence of
60-79 years. About 1 million cases of the dis-
ease and half a million deaths associated with
it are reported world-wide each year. Colorectal
cancer, however, is very uncommon in children
and adolescents. This is a presentation of 3
cases of colon cancer in Nigerians aged 17 and
19 years. Two of them were adenocarcinoma
and the other leiomyosarcoma. The pathogen-
esis  and  aspects  of  management  are  dis-
cussed.
Introduction
Colon cancers are the second most common
cancer in both men and women in America.
1,2
World-wide they are the third major cause of
cancer for men and the fourth most common
cause of cancer for women.
2,3 They are the sec-
ond  most  common  causes  of  cancer-related
deaths  in  developed  countries  and  the  most
common  gastro-intestinal  carcinoma.
4-6 The
incidence is highest in the westernized coun-
tries  of  North  America,  Northern  Europe,
Australia,  and  New  Zealand.  Intermediate
rates are found in Southern Europe, and low
rates in Africa.
2,4Reports have shown that close
to 1 million new cases of colo-rectal cancer and
nearly  half  a  million  deaths  associated  with
colorectal cancer are reported world-wide each
year.
4,7 About 98% of them are primary adeno-
carcinomas.
4,8,9 The remaining 2% are made up
of  carcinoid,  mesenchymal  and  lymphoid
tumors. These figures have decreased in the
West due to increased rate of screening and
polyp removal.
10
The peak incidence for colorectal carcinoma
is put at between ages 60 and 79 years, with
fewer than 20% occurring before the age of 50
years.
8 According  to  another  author,  90%  of
patients are older than 50 years; with highest
incidence rates in individuals aged 70 to 85
years.
4 Very occasionally, it may affect much
younger adults from the age of 20 years.
6
The risk factors for development of colo-rec-
tal cancer include age, a diet rich in fat and
cholesterol, inflammatory bowel disease, and
genetic  predisposition,  including  hereditary
polyposis and non-polyposis syndromes.
4,7,11
Three  cases  of  colonic  cancer  amongst
Nigerian adolescents aged 17 and 19 years are
presented. These are uncommon findings, and
hence  should  be  of  interest  to  clinicians  to
increase their index of suspicion as early cases
are potentially curable.
Case #1
OS, a 19-year old male student presented to
the surgical out-patient (SOP) department of
the Irrua Specialist Teaching Hospital (ISTH)
with  complaints  of  passage  of  bloody  and
watery stools, abdominal pain, lower abdomi-
nal distension and vomiting of between one
week and three months duration. The abdomi-
nal  pain  was  intermittent  and  colicky.  He
reported mild weight loss. There was no family
history of similar illness. Physical examination
showed a mildly dehydrated young man with
tense  and  distended  abdomen,  visible  peri-
staltic waves, and hyperactive bowel sounds.
He  was  admitted,  and  after  one  week  the
abdominal distension worsened and he devel-
oped constipation. Digital rectal examination
and proctoscopy showed an empty rectum with
a circumferential and fungating irregular, firm
mass about 5 cm from the anal verge.
An impression of intestinal obstruction sec-
ondary to rectal tumor was made, and incision-
al biopsy taken for histology. The histopatholo-
gy diagnosis was adenocarcinoma. The patient
was offered a dysfunctioning (loop) sigmoid
colostomy after decompression of the dilated
sigmoid  colon.  He  was  commenced  on  5-
flurouracil  (5FU)  and  adriamycin  following
confirmation  of  mesenteric  lymph  node
involvement in the colostomy biopsy specimen.
He  received  5  courses  of  chemotherapy  and
was referred to another center for radiothera-
py. The patients has responded well to this.
Case #2
EB was a 17-year old student. She presented
to the SOP of ISTH, six weeks after  appen-
dicectomy in a private hospital, with colicky
abdominal pain, vomiting, weakness, and dis-
charge from the appendicectomy scar of about
two weeks duration. Family and social history
was  not  significant.  Physical  examination
revealed a fixed and firm, non-fluctuant mass
of  about  10x11  cm  in  the  right  iliac  fossa
region of the abdomen. Abdominal ultrasound
found a large intra-abdominal mass, and sug-
gested retained foreign body, to rule out infect-
ed appendix stump. At exploratory laparotomy,
an infected appendicectomy wound and a firm
to hard cecal pole mass were observed. The
mass measured about 15x12 cm and was asso-
ciated  with  about  20  mls  of  abscess.  Right
hemi-colectomy was done and histopathology
examination requested. The request was never
received by the laboratory. The patient recov-
ered and was discharged home. Two months
post-operation, she developed a nodule on the
anterior abdominal wall over the laparotomy
scar. This was thought to be a pyogenic granu-
loma. A repeat abdominal ultrasound reported
an anterior abdominal wall mass and enlarged
inguinal lymph nodes, and made an impres-
sion  of  rhabdomyosarcoma.  The  lump  was
excised and sent for histopathology examina-
tion, together with the hemi-colectomy speci-
men. Both of them showed similar histologic
features  composed  of  malignant  glands  and
cells within fibro-cellular stroma. A diagnosis
of colonic adenocarcinoma with metastasis to
the  anterior  abdominal  wall  was  made.  The
patient was commenced on 5-FU and referred
for radiotherapy, after receiving 5 courses of
chemotherapy. She died about two and a half
years after diagnosis
Case #3
A  19-year  old  male,  PO,  presented  to  the
emergency  room  of  Joe  Alufohai  Medical
Center, Sabongida-Ora on 26/10/07 with a two-
week history of abdominal pain and vomiting.
On examination he was found to be in painful
distress and to have moderate rebound tender-
ness  and  guarding.  This  was  worse  over  the
right lower quadrant of the abdomen. A diagno-
sis  of  acute  appendicitis  was  made  and  the
patient taken in for emergency appendicectomy.
Findings  at  surgery  included  a  dilated,
longish and coiled appendix; dilated terminal
ileum; and an atrophic cecum with a localized
firm mass. In view of these findings, an addi-
tional intra-operative impression of congenital
hypertrophy of the ileo-cecal valve was consid-
ered and a limited right hemi-colectomy per-
formed. The specimen was sent for histology.
The patient did well and was discharged to the
out-patient clinic two weeks after surgery.
The  histopathology  diagnosis  was  leio-
myosarcoma, together with acute appendicitis.
The patient has yet to honor his out-patient
appointment, six months after discharge.
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Discussion
Almost all bowel cancers arise in the colo-
rectum, since the small intestine is strikingly
free from cancer risk.
6 Colon cancer is a silent
killer, often causing no recognizable symptoms
until it is too late.
3 Most of them occur sporad-
ically in the absence of well-defined familial
syndromes. Regardless of the inciting event, a
well-described set of genetic alterations occurs
that ultimately leads to colorectal malignancy.
8
Fitzgibbons  et  al. described  a  genetic  factor
found  in  young  patients  belonging  to
Scandinavian  families  with  the  Lynch  syn-
drome.
12
The vast majority of colorectal cancers are
adenocarcinomas, which arise from pre-exist-
ing adenomatous polyps.
6 This adenoma-carci-
noma sequence is a well-characterized clinical
and  histopathologic  series  of  events  with
which  discrete  molecular  genetic  alterations
have been associated.
7 However, about 30% of
colorectal carcinomas arise from flat lesions
without evidence of adenomatous precursors.
6
These suggest that some dysplastic lesions can
degenerate  into  malignancy  without  passing
through  a  polypoid  stage.
8 This  particularly
occurs with cancers of the proximal colon and
rectum.
6 Two of the cases being reported were
in the proximal colon; the third was in the rec-
tum. Sebbag et al. did not consider heredity to
be involved in the pathogenesis of colon can-
cer.
13 More recently though a known genetic
link  was  described  in  first  degree  biological
family members of persons with colon cancer.
3
They have 3 times greater risk of developing
colon  cancer  than  the  general  population.
However, 80% of colon cancers strike people
without genetic connection to the disease.
3 No
family history of similar illness was obtained
from any of the index patients. Vogelstein and
colleagues identified a number of very impor-
tant  genetic  alterations  that  contribute,
through their multiplicity over the years, to the
eventual development of colorectal cancer.
14,15
These are grouped into two pathogenetically
distinct  pathways  that  are  believed  to  be
responsible for the development of colon can-
cer.
16 Both pathways involve the stepwise accu-
mulation of multiple mutations. The first path-
way (APC/β-caterin pathway) is characterized
by  chromosomal  instability  that  results  in
accumulation of mutations in a series of onco-
genes  and  tumor  suppressor  genes.  These
include mutations of the adenomatous polypo-
sis coli (APC) gene and K-RAS gene, and loss
of SMAD4 (formerly called DPC4 – deleted in
pancreatic  cancer  –  gene)  and  p53 genes.
7,8
The  morphologic  evolution  of  the  lesion  is
through a localized colon epithelial prolifera-
tion to formation of small adenoma that pro-
gressively  enlarge,  become  more  dysplastic,
and  ultimately  develop  into  invasive  cancer
(the adenoma-carcinoma sequence). The sec-
ond  pathway  (microsatellite  instability  path-
way)  is  characterized  by  inheritance  of  a
mutation in one of several genes involved in
DNA mismatch repair, which are MSH2, MLH1,
MSH6, PMS1 and PMS2. It is involved in 10-
15% of sporadic cases of colon cancer and in
the  hereditary  non-polyposis  colonic  cancer
(HNPCC or Lynch) syndrome.
6-8 Inheritance in
this  type  of  cancer  is  autosomal  dominant.
Affected patients also carry an increased risk
of cancers of the stomach, ovaries, breast and
uterus.  The  colon  cancers  in  this  syndrome
tend to develop as flat lesions rather than as
polyps. Cancers arising through this pathway
occur  at  a  younger  age,  usually  before  45
years.
6 Unlike  in  the  adenoma-carcinoma
sequence, this pathway does not produce iden-
tifiable morphologic correlates.
These pathogenic pathways, which involve
stepwise accumulation of mutations, explain
why colorectal cancer is a disease of adults. It
is rare in patients under 40 years of age, and
even  rarer  in  younger  age  groups.
17 Of  the
1,250 cases seen by Sebbag et al. over a 25-year
period, only 3 (0.24%) were under 19 years.
13 It
is said that when colorectal cancer is found in
a young person, pre-existing ulcerative colitis
or one of the polyposis syndromes must be sus-
pected.
8 None of our cases had any of these.
Environmental factors, especially dietary prac-
tices,  have  been  implicated  in  the  observed
striking  geographic  contrasts  in  incidence.
People  who  eat  high  calorie,  high  fat
(Western) diets are at higher risk than people
who eat balanced low fat, high fiber (Eastern)
diets.
3,18 This is partly because fiber increases
the bulk and the transit time of stool. This does
not allow enough time for both bacterial break-
down of bile salts into carcinogenic lithocholic
and deoxycholic acids, and their contact with
colonic mucosa.
2 It had been mentioned that
low fecal pH had a role to play in the genesis of
colon cancer. Also the role of obesity in colorec-
tal  cancer  has  been  discussed.
20 There  is  a
well-known  link  between  obesity  and  a
Western  diet.  Japanese  and  Polish  families
who migrated from their low risk areas to the
US  acquired, over the course of 20 years, the
rate  prevailing  in  their  new  environment.
6
They had adopted the dietary practices of their
hosts.
8 Dietary factors account for 90% of the
risks for bowel cancer.
21 A Western-type dieting
has become very common with us in Africa,
even without migrating. This may account for
why the incidence in black Africans is increas-
ing, especially in the major urban cities.
2 Its
introduction to our children very early in life
may be an important influence when combined
with other environmental/racial/social factors
peculiar to us, which have not been studied.
After all, black Americans are said to be more
prone  to  developing  colon  cancer  than  their
white counterparts.
22 Apart from this, a possi-
ble increased risk among lower socioeconomic
groups especially in the third world has been
suggested.
23,24 This is related to poor nutrition
or chronic gastro-intestinal infections, such as
amoebiasis  and  schistosomiasis,  which  are
thought  to  be  associated  with  an  increased
incidence of malignancy. All three cases being
presented belonged to the lower socioeconom-
ic  group.  None  of  them  was  immunosup-
pressed.  Their  exposure  to  chronic  gastro-
intestinal infestations was not determined.
Colon cancers progress slowly and may be
asymptomatic for as many as five years or until
a much later phase.
9 However, patients usually
have occult blood losses from their tumor.
4 It is
likely that the index tumors started while the
patients were still in the pediatric age group.
Most studies suggest a delay in diagnosis with
an associated deleterious effect on outcome.
This is because many of the clinical features
are similar to those found in common child-
hood  problems  such  as  intussusception,
appendicitis, gastro-enteritis and simple con-
stipation.
23 Two of the presented cases were
initially  thought  to  be  appendicitis.  This  is
understandable considering the rarity of colon
cancer in children/adolescents.
Treatment must be aggressive and include a
combination of surgery and adjuvant chemo-
therapy. The surgical resection must be as rad-
ical as feasible for growth.
13 Both systemic and
loco-regional  chemotherapy,  such  as  intra-
hepatic,  intra-arterial  for  liver  metastasis,
have a role.
7 Where technically feasible, resec-
tion of metastatic deposits in the lungs or liver
is advisable.
25,26 The chemotherapeutic agents
in  use  include  5-FU,  irinotecan,  leucovorin,
and the more recent anti-vascular endothelial
growth  factor,  bevacizumab.
7 Radiotherapy
finds use in cases of rectal cancer to reduce
the risk of local recurrence. 
When  tumors  are  detected  early,  90%  of
patients survive at least five years after diag-
nosis and treatment.
27 This is not the case for
adolescents where it carries an extremely poor
prognosis, owing to late diagnosis and aggres-
sive tumor biology.
23
Conclusions
Colorectal cancer remains a leading cause
of death from cancer in adults, especially in
the Western world. It is a very rare disease in
children and adolescents. Even so, colon can-
cer in the young is of great concern, especially
since screening strategies are focused on older
patients.
17 Progress has been made in under-
standing the molecular basis of its predisposi-
tion and progression. Efforts are being made
on to develop better treatment and preventive
approaches,  and  better  screening  strategies.
Such  screening  strategies  must  incorporate
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children  and  adolescents  since  they  are  not
immune to colorectal cancers, as demonstrat-
ed by this report. As Sebbag et al. put it, the
distribution  pattern  of  colorectal  carcinoma
appears to have changed.
13 There is no point
waiting until older age to check for risks.
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